IBDEI0NL ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11612,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11612,1,1,0)
 ;;=1^173.91
 ;;^UTILITY(U,$J,358.3,11612,1,2,0)
 ;;=2^BCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,11612,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,11613,0)
 ;;=173.92^^79^761^51
 ;;^UTILITY(U,$J,358.3,11613,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11613,1,1,0)
 ;;=1^173.92
 ;;^UTILITY(U,$J,358.3,11613,1,2,0)
 ;;=2^SCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,11613,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,11614,0)
 ;;=173.99^^79^761^54
 ;;^UTILITY(U,$J,358.3,11614,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11614,1,1,0)
 ;;=1^173.99
 ;;^UTILITY(U,$J,358.3,11614,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,11614,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,11615,0)
 ;;=174.9^^79^761^8
 ;;^UTILITY(U,$J,358.3,11615,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11615,1,1,0)
 ;;=1^174.9
 ;;^UTILITY(U,$J,358.3,11615,1,2,0)
 ;;=2^BREAST CANCER-FEMALE
 ;;^UTILITY(U,$J,358.3,11615,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,11616,0)
 ;;=189.0^^79^761^48
 ;;^UTILITY(U,$J,358.3,11616,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11616,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,11616,1,2,0)
 ;;=2^RENAL CELL CANCER
 ;;^UTILITY(U,$J,358.3,11616,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,11617,0)
 ;;=149.0^^79^761^43
 ;;^UTILITY(U,$J,358.3,11617,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11617,1,1,0)
 ;;=1^149.0
 ;;^UTILITY(U,$J,358.3,11617,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,11617,2)
 ;;=^267051
 ;;^UTILITY(U,$J,358.3,11618,0)
 ;;=V66.7^^79^762^1
 ;;^UTILITY(U,$J,358.3,11618,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11618,1,1,0)
 ;;=1^V66.7
 ;;^UTILITY(U,$J,358.3,11618,1,2,0)
 ;;=2^Hospice/Palliative Care-USE w/ ea encounter
 ;;^UTILITY(U,$J,358.3,11618,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,11619,0)
 ;;=348.1^^79^763^1
 ;;^UTILITY(U,$J,358.3,11619,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11619,1,1,0)
 ;;=1^348.1
 ;;^UTILITY(U,$J,358.3,11619,1,2,0)
 ;;=2^ANOXIC BRAIN DAMAGE
 ;;^UTILITY(U,$J,358.3,11619,2)
 ;;=^7979
 ;;^UTILITY(U,$J,358.3,11620,0)
 ;;=348.5^^79^763^2
 ;;^UTILITY(U,$J,358.3,11620,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11620,1,1,0)
 ;;=1^348.5
 ;;^UTILITY(U,$J,358.3,11620,1,2,0)
 ;;=2^CEREBRAL EDEMA
 ;;^UTILITY(U,$J,358.3,11620,2)
 ;;=^16710
 ;;^UTILITY(U,$J,358.3,11621,0)
 ;;=348.4^^79^763^3
 ;;^UTILITY(U,$J,358.3,11621,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11621,1,1,0)
 ;;=1^348.4
 ;;^UTILITY(U,$J,358.3,11621,1,2,0)
 ;;=2^COMPRESSION OF BRAIN
 ;;^UTILITY(U,$J,358.3,11621,2)
 ;;=^27114
 ;;^UTILITY(U,$J,358.3,11622,0)
 ;;=291.1^^79^763^7
 ;;^UTILITY(U,$J,358.3,11622,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11622,1,1,0)
 ;;=1^291.1
 ;;^UTILITY(U,$J,358.3,11622,1,2,0)
 ;;=2^DEMENTIA,ALCOHOL-INDUCED
 ;;^UTILITY(U,$J,358.3,11622,2)
 ;;=^331823
 ;;^UTILITY(U,$J,358.3,11623,0)
 ;;=331.0^^79^763^8
 ;;^UTILITY(U,$J,358.3,11623,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11623,1,1,0)
 ;;=1^331.0
 ;;^UTILITY(U,$J,358.3,11623,1,2,0)
 ;;=2^DEMENTIA,ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,11623,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,11624,0)
 ;;=292.82^^79^763^9
 ;;^UTILITY(U,$J,358.3,11624,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11624,1,1,0)
 ;;=1^292.82
 ;;^UTILITY(U,$J,358.3,11624,1,2,0)
 ;;=2^DEMENTIA,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,11624,2)
 ;;=^331832
 ;;^UTILITY(U,$J,358.3,11625,0)
 ;;=290.40^^79^763^10
 ;;^UTILITY(U,$J,358.3,11625,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11625,1,1,0)
 ;;=1^290.40
 ;;^UTILITY(U,$J,358.3,11625,1,2,0)
 ;;=2^DEMENTIA,VASCULAR
 ;;^UTILITY(U,$J,358.3,11625,2)
 ;;=^10350
